Sandford D. Smith, Director at Aegerion Pharmaceuticals, Inc. (AEGR), sold 10,000 shares at $92.25 ($923K) on 2013-08-12, disclosed to the SEC on 2013-08-13.
Open-market sale of $923k AEGR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.33 | 8,463 | $781K | 84.6% |
| 2 | $92.25 | 1,537 | $142K | 15.4% |
| Total | $92.32 avg | 10,000 | $923K | 100% |
| Filing → |
| CYTK | SELL | 2021-11-19 | $1.4M | — | Filing → |
| CYTK | SELL | 2021-07-21 | $403K | — | Filing → |
| CYTK | SELL | 2021-04-27 | $401K | — | Filing → |